ID   OVB3
AC   CVCL_3109
SY   OVB-3
DR   CLO; CLO_0008277
DR   ATCC; HB-9147
DR   Wikidata; Q54936914
RX   Patent=US4806494;
RX   PubMed=3135309;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9147.
CC   Monoclonal antibody isotype: IgG2a+IgG2b.
CC   Monoclonal antibody target: Human antigen on ovarian cancer cell lines (Note=Immunized against OVCAR-3 (Cellosaurus=CVCL_0465)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
RX   Patent=US4806494;
RA   Pastan I., FitzGerald D.J.P., Willingham M.C.;
RT   "Monoclonal antibody against ovarian cancer cells (OVB-3).";
RL   Patent number US4806494, 21-Feb-1989.
//
RX   PubMed=3135309; DOI=10.4049/jimmunol.141.3.1034;
RA   Gallo M.G., Chaudhary V.K., FitzGerald D.J.P., Willingham M.C.,
RA   Pastan I.;
RT   "Cloning and expression of the H chain V region of antibody OVB3 that
RT   reacts with human ovarian cancer.";
RL   J. Immunol. 141:1034-1040(1988).
//